Hemochromatosis: New insights in pathogenesis and diagnosis following the discovery of the gene

Critical Reviews in Clinical Laboratory Sciences

Volumn 35, Issue 3, 1998, Pages 239-273

  Adams, Paul C ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHELATING AGENT; DEFEROXAMINE; FERRITIN; IRON; TRANSFERRIN; TRANSFERRIN RECEPTOR;

GENETIC SCREENING; HEMOCHROMATOSIS; HLA TYPING; HUMAN; IRON METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PHLEBOTOMY; PRIORITY JOURNAL; REVIEW;

ANIMALS; EUROPE; HEMOCHROMATOSIS; HUMANS; IRON; LIVER;

EID: 0031824825     PISSN: 10408363     EISSN: None     Source Type: Journal    
DOI: 10.1080/10408369891234200     Document Type: Review

References (85)

1. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nature Genetics 1996; 13: 399-408.
2. Sheldon JH. Haemochromatosis. pp. 164-340. Oxford Medical Publications, 1935.
3. Simon M, Bourel M, Genetet B, et al. Idiopathic hemochromatosis. Demonstration of recessive transmission and early detection by family HLA typing. N Engl J Med. 1977; 297: 1017-21.
4. Merryweather-Clarke A, Pointon J, Sherman J, et al. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997; 34: 275-8.
5. Fleming M, Trenor C, Su M, Foernzler D, et al. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nature Genetics 1997; 16: 383-6.
6. Gunshin H, Mackenzie B, Berger U, et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997; 388: 482-8.
7. Klausner RD, Rouault TA Harford JB. Regulating the fate of mRNA: The control of cellular iron metabolism. Cell 1993; 72: 19-28.
8. Pietrangelo A, Casalgrandi G, Quaglino D, et al. Duodenal ferritin synthesis in genetic hemochromatosis. Gastroenterology 1995; 108: 208-17.
9. Flanagan PR, Hajdu A Adams PC. Iron regulatory element binding protein in hemochromatosis liver and intestine. Hepatology 1995; 22: 828-32.
10. Zhou XY, Tomatsu S, Fleming R, et al. Knockout of the mouse HFE gene produces hemochromatosis. Proc Natl Acad Sci USA 1998; 95: 2492-97.
11. Feder J, Tsuchihashi Z, Irrinki A, et al. The hemochromatosis founder mutation in HLA-H disrupts beta-2-microglobulin interaction and cell surface expression. J Biol Chem 1997; 272: 14025-8.
12. Parkkila S, Waheed A, Britton R, et al. Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci USA 1997; 94: 13198-202.
13. Feder J, Penny D, Irrinki A, et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci USA 1998; 95: 1472-7.
14. Sciot R, Paterson AC, Van Den Oord JJ, et al. Lack of hepatic transferrin receptor expression in hemochromatosis. Hepatology 1987; 7: 831-7.
15. Adams PC, Chau LA, White M, et al. Expression of transferrin receptors on monocytes in hemochromatosis. Am J Hematol 1991; 37: 247-52.
16. Banerjee D, Flanagan PR, Cluett J, et al. Transferrin receptors in the human gastrointestinal tract. Relationship to body iron stores. Gastroenterology 1986; 91: 861-9.
17. Toyokuni S, Sagripanti JL. Iron-mediated DNA damage - sensitive detection of DNA strand breakage catalyzed by iron. J Inorganic Biochemistry 1992; 47: 241-8.
18. Adams PC, Deugnier Y, Moirand R, et al. The relationship between iron overload, clinical symptoms and age in 410 patients with genetic hemochromatosis. Hepatology 1997; 25: 162-6.
19. Moirand R, Adams PC, Bicheler V, et al. Clinical features of genetic hemochromatosis in women compared to men. Ann Int Med 1997; 127: 105-10.
20. Adams PC. Hepatocellular carcinoma in hereditary hemochromatosis. Can J Gastroenterol 1993; 7: 37-41.
21. Hramiak I, Finegood D Adams PC. Factors affecting glucose tolerance in hereditary hemochromatosis. Clin Invest Med 1997; 20: 110-8.
22. Niederau C, Berger M, Stremmel W, et al. Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation. Diabetologia 1984; 26: 441-4.
23. Kaltwasser JP, Schalk KP Werner E. Juvenile hemochromatosis. Ann NY Acad Med 1988; 526: 339-41.
24. Adams PC, Speechley M. The effect of arthritis on the quality of life in hereditary hemochromatosis. J Rheumatol 1996; 23: 707-10.
25. Diamond T, Stiel D Posen S. Osteoporosis in hemochromatosis: iron excess, gonadal deficiency, or other factors? Ann Intern Med 1989; 110: 430-6.
26. Cullen LM, Sommerville L, Crawford DHG, et al. The haemochromatosis defect in Australia: population frequency indicates level of expression and positive selection for the defect. [Abstract] Blood 1998; (in press).
27. Adams PC, Valberg LS. Evolving expression of hereditary hemochromatosis. Sem Liv Dis 1996; 16: 47-54.
28. Balan V, Baldus W, Fairbanks V, et al. Screening for hemochromatosis: a cost-effectiveness study based on 12,258 patients. Gastroenterology 1994; 107: 453-9.
29. Brissot P, Bourel M, Kerry D, et al. Assessment of liver iron content in 271 patients: a reevaluation of direct and indirect methods. Gastroenterology 1981; 80: 557-65.
30. Adams PC, Kertesz AE Valberg LS. Clinical presentation of hemochromatosis: a changing scene. Am J Med 1991; 90: 445-9.
31. Adams PC, Chakrabarti S. Genotypic/phenotypic correlations in genetic hemochromatosis: evolution of diagnostic criteria. Gastroenterology 1998; 114: 319-23.
32. Adams PC, Deugnier Y, Moirand R, et al. Relationship between age, ferritin, and cirrhosis in genetic hemochromatosis: implications for liver biopsy. [Abstract] Hepatology 1997; 26: 468A
33. Adams PC, Speechley M Kertesz AE. Long-term survival analysis in hereditary hemochromatosis. Gastroenterology 1991; 101: 368-72.
34. Niederau C, Fischer R, Purschel A, et al. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996; 110: 1107-19.
35. Fargion S, Mandelli C, Piperno A, et al. Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis. Hepatology 1992; 15: 655-9.
36. Bassett ML, Halliday JW Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology 1986; 6: 24-9.
37. Adams PC, Bradley C Henderson AR. Evaluation of the hepatic iron index as a diagnostic criterion in hereditary hemochromatosis. J Lab Clin Med 1997; 130: 509-14.
38. Ludwig J, Hashimoto E, Porayko M, et al. Hemosiderosis in cirrhosis: a study of 447 native livers. Gastroenterology 1997; 112: 882-8.
39. Guyader D, Gandon Y, Robert JY, et al. Magnetic resonance imaging and assessment of liver iron content in genetic hemochromatosis. J Hepatol 1992; 15: 304-8.
40. Adams PC, Kertesz AE. Human leukocyte antigen typing of siblings in hereditary hemochromatosis: a cost approach. Hepatology 1992; 15: 263-8.
41. Jazwinska EC, Pyper WR, Burt MJ, et al. Haplotype analysis in Australian hemochromatosis patients: evidence for a predominant ancestral haplotype exclusively associated with hemochromatosis. Am J Hum Genet 1995; 56: 428-33.
42. Stone C, Pointon JJ, Jazwinska EC, et al. Isolation of CA dinucleotide repeats close to d6s105; linkage disequilibrium with haemochromatosis. Hum Mol Genet 1994; 3: 2043-6.
43. Jouanolle A-M, Gandon G, Jezequel P, et al. Haemochromatosis and HLA-H. Nature Genetics 1996; 14: 251-2.
44. The UK Haemochromatosis Consortium. A simple genetic test identifies 90% of UK patients with haemochromatosis. Gut 1997; 41: 841-5.
45. Bacon BR, Schratz C, Britton RS, et al. Presence of the hemochromatosis genotype in patients with liver disease. [Abstract] Gastroenterology 1997; 112: A1218
46. Minguillan J, Lee R, Britton R, et al. Genetic markers for hemochromatosis in patients with cirrhosis and iron overload. [Abstract] Hepatology 1997; 26: 158A
47. Adams PC. Implications of genotyping of spouses to limit investigation of children in genetic hemochromatosis. Clinical Genetics 1998 53: 176-8.
48. Carella M, D'Ambrosio L, Totaro A, et al. Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. Am J Hum Genet 1997; 60: 828-32.
49. Adams PC. Factors affecting rate of iron mobilization during venesection therapy for hereditary hemochromatosis. Am J Hematology 1998; 58: 16-19.
50. Edwards CQ, Kushner JP. Screening for hemochromatosis. N Engl J Med 1993; 328: 1616-20.
51. Powell LW. Hemochromatosis: the impact of early diagnosis and therapy. Gastroenterology 1996; 110: 1304-7.
52. Edwards CQ, Griffen LM, Goldgar D, et al. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med 1988; 318: 1355-62.
53. Velati C, Piperno A, Fargion S, et al. Prevalence of idiopathic hemochromatosis in Italy: study of 1301 blood donors. Haematologica 1990; 75: 309-12.
54. Wiggers P, Dalhoj J, Kiaer H, et al. Screening for haemochromatosis: prevalence among Danish blood donors. J Intern Med 1991; 230: 265-70.
55. Adams PC, Kertesz AE, Barr R, et al. Population screening for hemochromatosis with the unbound iron binding capacity. [Abstract] Gastroenterology 1998; 114: A1199.
56. Hallberg L, Bjorn-Rasmussen E Jungner I. Prevalence of hereditary haemochromatosis in two Swedish urban areas. J.Intern.Med. 1989; 225: 249-55.
57. Baer DM, Simons JL, Staples RL, et al. Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older. Am J Med 1995; 98: 464-8.
58. Leggett BA, Halliday JW, Brown NN, et al. Prevalence of haemochromatosis amongst asymptomatic Australians. Br J Haematol 1990; 74: 525-30.
59. O'Brien T, Barrett B, Murray DM, et al. Usefulness of biochemical screening of diabetic patients for hemochromatosis. Diabet Care 1990; 13: 532-4.
60. Olsson KS, Marsell R, Ritter B, et al. Iron deficiency and iron overload in Swedish male adolescents. J Intern Med 1995; 237: 187-94.
61. Olynyk J, Marshall H, Crostella L, et al. Population screening for the hemochromatosis mutation and biochemical expression. [Abstract] Hepatology 1997; 26: 199A
62. Buffone GJ, Beck JR. Cost-effectiveness analysis for evaluation of screening programs: hereditary hemochromatosis. Clin Chem 1994; 40: 1631-6.
63. Phatak PD, Guzman G, Woll JE, et al. Cost-effectiveness of screening for hereditary hemochromatosis. Arch Intern Med 1994; 154: 769-76.
64. Adams PC, Gregor JC, Kertesz AE, et al. Screening blood donors for hereditary hemochromatosis: decision analysis model based on a thirty-year database. Gastoenterology 1995; 109: 177-88.
65. Kowdley K, Kaur S Hassanien T. Primary liver cancer and survival in patients undergoing orthotopic liver transplantation for hemochromatosis. J Liver Trans Surg 1995; 1: 237-41.
66. Porter DR, Sturrock RD Capell HA. The use of serum ferritin estimation in the investigation of anaemia in patients with rheumatoid arthritis. Clin Exp Rheumatol 1994; 12: 179-82.
67. Kaye TB, Guay AT. Increased Serum Ferritin Levels in Patients with Diabetes Mellitus. Mayo Clin Proc 1994; 69: 498-9.
68. Cohen C, Berson SD, Shulman G, et al. Liver iron stores and hepatitis B antigen status. Cancer 1985; 56: 2202-A
69. LeSage GD, Baldus WP, Fairbanks VF, et al. Hemochromatosis: genetic or alcohol-induced? Gastroenterology 1983; 84: 1471-7.
70. Adams PC, Agnew S. Alcoholism in hereditary hemochromatosis revisited: prevalence and clinical consequences among homozygous siblings. Hepatology 1996; 23: 724-7.
71. Boucher E, Bourienne A, Adams PC, et al. Liver iron concentration and distribution during therapy for chronic hepatitis C. Gut 1997; 41: 115-20.
72. Bacon BR. Iron and hepatitis C. Gut 1997; 41: 127-8.
73. Edwards CQ, Griffen LM, Goldgar DE, et al. HLA-linked hemochromatosis alleles in sporadic porphyria cutanea tarda. Gastroenterology 1989; 97: 972-81.
74. Beaumont C, Fauchet R, Phung LN, et al. Porphyria cutanea tarda and HLA-linked hemochromatosis. Evidence against a systematic association. Gastroenterology 1987; 92: 1833-8.
75. Beutler E. Genetic irony beyond haemochromatosis: clinical effects of HLA-H mutations. Lancet 1997; 349: 296-7.
76. Stuart K, Busfield F, Jazwinska E, et al. The C282Y mutation in HFE is common in Australian patients and can act indepedently of HCV to precipitate porphyria cutanea tarda. [Abstract] Hepatology 1997; 26: 606A
77. Gordeuk V, Mukiibi J, Hasstedt SJ, et al. Iron overload in Africa. Interaction between a gene and dietary iron content. N Engl J Med 1992; 326: 95-100.
78. Adams PC, Bradley C Frei JV. Hepatic iron and zinc concentrations after portacaval shunting for nonalcoholic cirrhosis. Hepatology 1994; 19: 101-5.
79. Moirand R, Mortaji A, Loreal O, et al. A new syndrome of liver iron overload with normal transferrin saturation. Lancet 1997; 349: 95-7.
80. Wurapa RK, Gordeuk V, Brittenham G, et al. Primary iron overload in African Americans. Am J Med 1996; 100: 9-18.
81. Eason RJ, Adams PC, Aston CE, et al. Familial iron overload with possible autosomal dominant inheritance. Aust NZ J Med 1990; 20: 226-30.
82. Oliver M, Scully L, Guiraudon C, et al. Non-HLA linked hemochromatosis in a Chinese woman. Dig Dis Sci 1995; 40: 1589-91.
83. Egawa H, Berquist W, Garcia-Kennedy R, et al. Rapid development of hepatocellular siderosis after liver transplantation for neonatal hemochromatosis. Transplantation 1997; 62: 1511-3.
84. Cazzola M, Bergamaschi G, Tonon L, et al. Hereditary hyperferritinemia-cataract syndrome: relationship between phenotypes and specific mutations in the iron-responsive element of ferritin light-chain mRNA. Blood 1997; 90: 814-21.
85. Girelli D, Corrocher R, Biscelglia L, et al. Hereditary hyperferritinemia-cataract syndrome caused by a 29-base pair deletion in the iron responsive element of ferritin L-subunit gene. Blood 1997; 90: 2084-8.